Total Payments
$13,626
2024 Payments
$3,001
Companies
42
Transactions
329
Medicare Patients
21,212
Medicare Billing
$918,796
Payment Breakdown by Category
Food & Beverage$8,168 (59.9%)
Consulting$2,194 (16.1%)
Other$1,500 (11.0%)
Travel$1,340 (9.8%)
Education$423.38 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,168 | 314 | 59.9% |
| Consulting Fee | $2,194 | 5 | 16.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,500 | 2 | 11.0% |
| Travel and Lodging | $1,340 | 6 | 9.8% |
| Education | $423.38 | 2 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HEARTFLOW, INC. | $3,440 | 9 | $0 (2024) |
| Boston Scientific Corporation | $1,943 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,365 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $983.68 | 61 | $0 (2024) |
| GE HEALTHCARE | $908.00 | 4 | $0 (2023) |
| Edwards Lifesciences Corporation | $736.81 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $552.57 | 31 | $0 (2024) |
| Abbott Laboratories | $471.01 | 14 | $0 (2024) |
| Amgen Inc. | $451.94 | 24 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $424.06 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,001 | 65 | HEARTFLOW, INC. ($1,536) |
| 2023 | $3,693 | 50 | HeartFlow, Inc. ($1,773) |
| 2022 | $778.90 | 23 | Boston Scientific Corporation ($261.26) |
| 2021 | $587.68 | 6 | BOSTON SCIENTIFIC CORPORATION ($236.37) |
| 2020 | $971.61 | 16 | GE HEALTHCARE ($571.00) |
| 2019 | $1,429 | 64 | Janssen Pharmaceuticals, Inc ($275.45) |
| 2018 | $1,871 | 60 | Merck Sharp & Dohme Corporation ($930.78) |
| 2017 | $1,294 | 45 | Merck Sharp & Dohme Corporation ($417.13) |
All Payment Transactions
329 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Heart Failure | ||||||
| 12/27/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Heart Failure | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.70 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $27.41 | General |
| 10/24/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/22/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.92 | General |
| 10/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $18.31 | General |
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.00 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Cardiology | ||||||
| 08/29/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.87 | General |
| 08/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $121.98 | General |
| Category: Transcatheter Heart Valves | ||||||
| 08/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/12/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $32.72 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/25/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $35.95 | General |
| Category: Coronary | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/11/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 5,371 | 6,895 | $1.1M | $233,696 |
| 2022 | 30 | 5,550 | 7,103 | $1.0M | $237,756 |
| 2021 | 29 | 5,314 | 6,436 | $977,112 | $237,730 |
| 2020 | 29 | 4,977 | 6,107 | $908,373 | $209,614 |
Total Patients
21,212
Total Services
26,541
Medicare Billing
$918,796
Procedure Codes
156
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 607 | 787 | $193,602 | $76,073 | 39.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 178 | 284 | $40,896 | $18,705 | 45.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 213 | $37,275 | $15,024 | 40.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 261 | 263 | $158,063 | $14,095 | 8.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,886 | 2,253 | $78,855 | $14,062 | 17.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 101 | 101 | $28,381 | $10,908 | 38.4% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 117 | 118 | $129,328 | $10,887 | 8.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 725 | 934 | $74,720 | $10,779 | 14.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 185 | 185 | $111,185 | $9,576 | 8.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 65 | $26,065 | $9,076 | 34.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 68 | 76 | $15,656 | $7,631 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $17,836 | $6,912 | 38.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 52 | 642 | $21,186 | $5,270 | 24.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 82 | 82 | $18,860 | $4,948 | 26.2% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 39 | 42 | $14,826 | $3,613 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,537 | $1,870 | 41.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 19 | 21 | $11,529 | $1,850 | 16.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,872 | $1,408 | 36.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 125 | 126 | $12,474 | $1,322 | 10.6% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Facility | 2023 | 21 | 60 | $5,520 | $1,316 | 23.8% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 22 | 22 | $4,879 | $1,214 | 24.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 52 | 52 | $26,000 | $1,074 | 4.1% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 23 | 23 | $4,830 | $1,062 | 22.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 77 | 77 | $7,623 | $809.90 | 10.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 99 | 103 | $3,605 | $644.74 | 17.9% |
About Dr. Michael Bauer, M.D
Dr. Michael Bauer, M.D is a Cardiovascular Disease healthcare provider based in Arlington Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205832128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Bauer, M.D has received a total of $13,626 in payments from pharmaceutical and medical device companies, with $3,001 received in 2024. These payments were reported across 329 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,168).
As a Medicare-enrolled provider, Bauer has provided services to 21,212 Medicare beneficiaries, totaling 26,541 services with total Medicare billing of $918,796. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Arlington Heights, IL
- Active Since 06/24/2005
- Last Updated 04/26/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1205832128
Products in Payments
- FFRct (Device) $3,440
- WATCHMAN Access System (Device) $1,126
- MK-1242 (Drug) $930.78
- XARELTO (Drug) $552.57
- WATCHMAN (Device) $524.70
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $502.82
- LEQVIO (Drug) $492.46
- ENTRESTO (Drug) $491.22
- ZERBAXA (Drug) $417.13
- MUSE (Device) $337.00
- PRADAXA (Drug) $261.96
- ELIQUIS (Drug) $249.33
- CARDIOMEMS (Device) $221.92
- Repatha (Biological) $214.57
- Corlanor (Drug) $209.96
- MITRACLIP (Device) $208.09
- WATCHMAN FLX (Device) $205.70
- LifeVest (Device) $199.40
- BRILINTA (Drug) $192.96
- JARDIANCE (Drug) $162.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Arlington Heights
Dr. Steven Lupovitch, M.d, M.D
Cardiovascular Disease — Payments: $41,286
Cardiovascular Disease $41,286
Alan Spiegel, M.d, M.D
Cardiovascular Disease — Payments: $12,017
Cardiovascular Disease $12,017
Dr. Stephen Zaacks, M.d, M.D
Cardiovascular Disease — Payments: $8,795
Cardiovascular Disease $8,795
Dr. Narayan Saha, M.d, M.D
Cardiovascular Disease — Payments: $4,136
Cardiovascular Disease $4,136
William Suhr, M.d, M.D
Cardiovascular Disease — Payments: $3,515
Cardiovascular Disease $3,515
Dr. Paul Ruzumna, M.d, M.D
Cardiovascular Disease — Payments: $2,479
Cardiovascular Disease $2,479